401(k) · DOL Form 5500 · 2024

Asklepios Biopharmaceutical, Inc. 401(k) Plan

Data updated 2026-08-25

$33M
Total assets Below avg plan size
394
Participants Below avg headcount
79th
Percentile by assets National rank
$84,932
Avg per participant Below avg balance/head
PlainRetire home → About this data RSS: change history

Official DOL plan name: Asklepios Biopharmaceuticals, Inc. 401(k) Plan · Sponsored by Asklepios Biopharmaceutical, Inc. · North Carolina · Professional & Technical Services

$33M in assets, 394 participants

Asklepios Biopharmaceutical, Inc.'s Asklepios Biopharmaceuticals, Inc. 401(k) Plan reported $33M in total assets and 394 participants in its 2024 DOL Form 5500 filing, ranking in the 79th percentile by assets among filed plans. Figures are as reported by the plan sponsor to the Department of Labor, not audited or endorsed by PlainRetire.

  • #15,978 in Professional & Technical Services (20,173 peers)

Coverage in North Carolina

Asklepios Biopharmaceuticals, Inc. 401(k) Plan covers 394 participants in North Carolina, about 48% of the average North Carolina filer (state average ~819 per filing). Assets: $33M.

#15,978
in Professional & Technical Services (20,173 peers)
+52.0%
assets growth YoY
0.3×
vs typical plan assets (national mean)

Asklepios Biopharmaceuticals, Inc. 401(k) Plan's outsized position by total assets

Asklepios Biopharmaceuticals, Inc. 401(k) Plan vs every filed plan by assets

End-of-year total assets · plan year 2024 · DOL Form 5500

$33,463,177 Top 21% higher than 79% of 123,620 filed plans

This plan $0 $2,050,000,000 every filed plan with reported assets, bucketed by value

Dashed line + filled bar = this entry, among filed plans.

Source U.S. Department of Labor Form 5500 filings (EBSA) · plan year 2024

Asklepios Biopharmaceuticals, Inc. 401(k) Plan among mid-size filed plans by headcount

Plan-year 2024 Form 5500 filings with a reported participant count, partitioned by headcount band, not by assets. Asklepios Biopharmaceuticals, Inc. 401(k) Plan sits mid-pack in the medium band (394 participants).

What changed between DOL Form 5500 filings

plan year 2023 → plan year 2024

  • Asklepios Biopharmaceuticals, Inc. 401(k) Plan end-of-year assets rose from $22M in the plan year 2023 filing to $33M in the plan year 2024 filing.
  • Asklepios Biopharmaceuticals, Inc. 401(k) Plan reported participants rose from 303 in the plan year 2023 filing to 394 in the plan year 2024 filing.
  • Asklepios Biopharmaceuticals, Inc. 401(k) Plan reported net income rose from $11M in the plan year 2023 filing to $11M in the plan year 2024 filing.

See the national 2023→2024 release diff →

EBSA filing schedule strip

Filing strip 200267834 · Asklepios Biopharmaceutical, Inc. PY 2024 · 401(k)

Asklepios Biopharmaceuticals, Inc. 401(k) Plan · $33M · 394 · 79th

  • BOOK $33M
  • BOOK 394
  • BOOK 79th
  • BOOK 401(k)
  • BOOK near Avanzar Interior Technologies, Ltd Savings and Investment (401(k)) Plan
  • BOOK ind #15978

Stamps derive from this plan's Form 5500 line items (assets, participants, type, EIN, cohort placement) - not a quality rating of the sponsor. Read with Professional & Technical Services retirement plans → · Plans in North Carolina →

Asklepios Biopharmaceuticals, Inc. 401(k) Plan in the asset neighbourhood

Ace Endico Corp. 401(k) Plan$33MKoetter Construction 401(k) Retirement PlanKoetter Construction 401(k) …$33MAsklepios Biopharmaceuticals, Inc. 401(k) PlanAsklepios Biopharmaceuticals…$33MAvanzar Interior Technologies, Ltd Savings and Investment (401(k)) PlanAvanzar Interior Technologie…$33MJ & J Ventures Gaming, LLC 401(k) Savings Plan and TrustJ & J Ventures Gaming, LLC 4…$33M
End-of-year total assets ($M) among Asklepios Biopharmaceuticals, Inc. 401(k) Plan and nearest nationwide 401(k) peers. Source: DOL Form 5500 plan year 2024.

North Carolina filing particulars

Total Assets (Beginning of Year)$22M
Net Assets (End of Year)$33M
Net Income$11M
Employer EIN200267834
Plan Effective Date2018-01-01
Filing StatusFILING RECEIVED

Sponsor Plan History (Asklepios Biopharmaceutical, Inc.)

Sponsor-wide plan assets over time

All Asklepios Biopharmaceutical, Inc. plans reported in each filing year

Latest sponsor-wide plan assets
$33M 194.89140769255104% vs 2022
2024 filing year
$0M$10M$20M$30M$40M 202220232024 $11.4M $33.5M ▲ +194.8%
Year Plans Participants Total Assets
2022 1 196 $11M
2023 1 303 $22M
2024 1 394 $33M

Nearby 401(k) Plans in North Carolina

Peer 401(k) plans, same state, same plan type, ranked by total assets.

Asklepios Biopharmaceuticals, Inc. 401(k) Plan vs. nearby 401(k) plans in North Carolina, assets vs. participants Scatter plot of 6 data points. -50000050000100000150000200000 -20020406080 Total assets ($B) Participants Asklepios Biopharmaceuticals, Inc. 401(k) Plan, Total assets ($B): 0.033463177 · Participants: 394Asklepios Biopharmaceuticals, Inc. 401(k) PlanThe Bank of America 401(k) Plan, Total assets ($B): 62.902405616 · Participants: 168963The Bank of America 401(k) PlanHoneywell 401(k) Plan, Total assets ($B): 16.316486587 · Participants: 39468Honeywell 401(k) PlanDuke Energy Retirement Savings Plan, Total assets ($B): 11.269744 · Participants: 27341Duke Energy Retirement Savings PlanNucor Corporation Profit Sharing and Retirement Savings Plan, Total assets ($B): 9.349291649 · Participants: 27070Nucor Corporation Profit Sharing and Retirement Savings PlanTruist Financial Corporation 401(k) Savings Plan, Total assets ($B): 9.231001739 · Participants: 52699Truist Financial Corporation 401(k) Savings Plan
Asklepios Biopharmaceuticals, Inc. 401(k) Plan vs. nearby 401(k) plans in North Carolina, assets vs. participants
Compare Asklepios Biopharmaceuticals, Inc. 401(k) Plan side-by-side with 3 peers →

Asklepios Biopharmaceuticals, Inc. 401(k) Plan's out-of-state 401(k) peers by assets and headcount

Outside North Carolina, the nearest 401(k) by assets is Avanzar Interior Technologies, Ltd Savings and Investment (401(k)) Plan in MI ($33M); by covered participants it is Calm.Com, Inc. 401(k) Plan in CA (394 participants). Same-state nearby plans are listed separately above.

Similar participant headcount

Nearest other-state filings by covered participants (394 participants); asset peers above are excluded.

DOL Form 5500 plan year 2024. Asset totals can differ widely at the same headcount; neither axis is a quality rating.

Frequently Asked Questions

How did Asklepios Biopharmaceuticals, Inc. 401(k) Plan assets move in 2024? ▼
Asklepios Biopharmaceuticals, Inc. 401(k) Plan surged - up 52.0% during 2024, from $22M to $33M. Reported net income was $11M.
How have Asklepios Biopharmaceutical, Inc. plan assets changed over time? ▼
Across 3 plan years on file (2022-2024), Asklepios Biopharmaceutical, Inc.'s sponsor-wide assets grew 194.9%, from $11M to $33M.
Where does Asklepios Biopharmaceuticals, Inc. 401(k) Plan rank by assets among Form 5500 filers? ▼
Asklepios Biopharmaceuticals, Inc. 401(k) Plan ranks in the 79th percentile by end-of-year assets among 123,622 plans that reported assets for plan year 2024 (in the top quartile of all filed plans by assets).
Which 401(k) plans are similar in size to Asklepios Biopharmaceuticals, Inc. 401(k) Plan? ▼
Among 401(k) plans in other states, the closest by assets is Avanzar Interior Technologies, Ltd Savings and Investment (401(k)) Plan in MI ($33M, 1,122 participants).
Which 401(k) plans cover a similar participant headcount to Asklepios Biopharmaceuticals, Inc. 401(k) Plan? ▼
Among 401(k) plans in other states, the closest by covered participants is Calm.Com, Inc. 401(k) Plan in CA (394 participants, $29M in assets).

Source: U.S. Department of Labor, Employee Benefits Security Administration (EBSA), Form 5500 public disclosure dataset. Plan year 2024.

Source: DOL EFAST2 filing system (efast.dol.gov) - original filing retrieval by EIN 200267834.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from U.S. Department of Labor Form 5500 filings (EBSA). See our methodology for details.